English
Insider transactions
EDGAROKYO Pharma Limited
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 7 transactions, 94,363 shares
- Sum of shares × price per share: 136,005.87
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–19 of 19
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 Filed 2026-08-07 | Patil Rajkumar V. Officer: Chief Scientific Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 3,363 | 1.49 | 5,010.87Derived: shares × price per share. Exact value 5010.87. | 20,030 | Direct (D) | No | — | Open filing 0001493152-26-036581 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | Patil Rajkumar V. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,363 | 1.49 | 5,010.87Derived: shares × price per share. Exact value 5010.87. | 20,030 | Direct (D) | No | — | Open filing 0001493152-26-035212 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-08-07 | Dempsey Robert John Director · Officer: CHIEF EXECUTIVE OFFICER | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 15,000 | 1.539 | 23,085Derived: shares × price per share. Exact value 23085.000. | 15,000 | Direct (D) | No | — | Open filing 0001493152-26-036584 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-23 | Dempsey Robert John Director · Officer: CHIEF EXECUTIVE OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 15,000 | 1.539 | 23,085Derived: shares × price per share. Exact value 23085.000. | 15,000 | Direct (D) | No | — | Open filing 0001493152-26-034409 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-08-07 | BRANCACCIO JOHN P Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 5,000 | 1.477 | 7,385Derived: shares × price per share. Exact value 7385.000. | 35,201 | Direct (D) | No | — | Open filing 0001493152-26-036585 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-08-07 | JACOB GARY S Director · Officer: CHIEF DEVELOPMENT OFFICER | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 3,500 | 1.4 | 4,900Derived: shares × price per share. Exact value 4900.0. | 112,420 | Direct (D) | No | — | Open filing 0001493152-26-036583 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-08-07 | Mantelli Flavio Officer: CHIEF MEDICAL OFFICER | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 20,000 | 1.4 | 28,000Derived: shares × price per share. Exact value 28000.0. | 20,000 | Direct (D) | No | — | Open filing 0001493152-26-036580 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-08-07 | CERRONE GABRIELE M Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 22,500 | 1.45 | 32,625Derived: shares × price per share. Exact value 32625.00. | 10,873,916 | Indirect (I) Via Panetta Partners Limited | No | — | Open filing 0001493152-26-036579 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-07-23 | CERRONE GABRIELE M Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 22,500 | 1.45 | 32,625Derived: shares × price per share. Exact value 32625.00. | 10,873,916 | Indirect (I) Via Panetta Partners Limited | No | — | Open filing 0001493152-26-034408 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-07-23 | JACOB GARY S Director · Officer: CHIEF DEVELOPMENT OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,500 | 1.40 | 4,900Derived: shares × price per share. Exact value 4900.00. | 112,420 | Direct (D) | No | — | Open filing 0001493152-26-034406 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-07-23 | BRANCACCIO JOHN P Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 5,000 | 1.477 | 7,385Derived: shares × price per share. Exact value 7385.000. | 35,201 | Direct (D) | No | — | Open filing 0001493152-26-034405 Read from the filing’s XML Dispute this row |
| 2026-07-21 Filed 2026-07-22 | Mantelli Flavio Officer: CHIEF MEDICAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 20,000 | 1.40 | 28,000Derived: shares × price per share. Exact value 28000.00. | 20,000 | Direct (D) | No | — | Open filing 0001493152-26-034236 Read from the filing’s XML Dispute this row |
| 2026-07-20 Filed 2026-08-07 | CERRONE GABRIELE M Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 25,000 | 1.4 | 35,000Derived: shares × price per share. Exact value 35000.0. | 10,851,416 | Indirect (I) Via Panetta Partners Limited | No | — | Open filing 0001493152-26-036582 Read from the filing’s XML Dispute this row |
| 2026-07-20 Filed 2026-07-21 | CERRONE GABRIELE M Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 1.40 | 35,000Derived: shares × price per share. Exact value 35000.00. | 10,851,416 | Indirect (I) Via Panetta Partners Limited | No | — | Open filing 0001493152-26-034084 Read from the filing’s XML Dispute this row |
| 2026-06-08 Filed 2026-06-10 | Denoyer Bernard Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,500 | 1.85 | 6,475Derived: shares × price per share. Exact value 6475.00. | 35,190 | Direct (D) | No | — | Open filing 0001493152-26-028134 Read from the filing’s XML Dispute this row |
| 2026-06-08 Filed 2026-06-10 | CERRONE GABRIELE M Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 300,000 | 1.72 | 516,000Derived: shares × price per share. Exact value 516000.00. | 10,826,416 | Indirect (I) Via Panetta Partners Limited | No | — | Open filing 0001493152-26-028117 Read from the filing’s XML Dispute this row |
| 2026-06-08 Filed 2026-06-10 | Simon Willy Jules Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 6,500 | 1.85 | 12,025Derived: shares × price per share. Exact value 12025.00. | 135,502 | Direct (D) | No | — | Open filing 0001493152-26-028132 Read from the filing’s XML Dispute this row |
| 2026-06-08 Filed 2026-06-10 | BRANCACCIO JOHN P Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 6,500 | 1.85 | 12,025Derived: shares × price per share. Exact value 12025.00. | 138,394 | Direct (D) | No | — | Open filing 0001493152-26-028133 Read from the filing’s XML Dispute this row |
| 2026-06-08 Filed 2026-06-10 | Shah Keeren Rameshchandra Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,000 | 1.85 | 74,000Derived: shares × price per share. Exact value 74000.00. | 544,819 | Direct (D) | No | — | Open filing 0001493152-26-028131 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–19 of 19
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Woodline Partners LP | 3,653,531 SH | 4,713,055 dollars | Higher by 763 Prior quarter: 3,652,768 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| Opaleye Management Inc. | 1,620,000 SH | 2,089,800 dollars | Higher by 1,244,796 Prior quarter: 375,204 | Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row |
| Stonepine Capital Management, LLC | 914,367 SH | 1,179,533 dollars | Higher by 51,371 Prior quarter: 862,996 | Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row |
| Balyasny Asset Management L.P. | 680,941 SH | 878,414 dollars | Higher by 100,345 Prior quarter: 580,596 | Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 36,964 SH | 47,684 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 33,527 SH | 43,250 dollars | Lower by 4,242 Prior quarter: 37,769 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| CHOREO, LLC | 33,255 SH | 42,899 dollars | Unchanged Prior quarter: 33,255 | Open filing 0001214659-26-013321 Filed 2026-10-28 Dispute this row |
| Quantinno Capital Management LP | 33,255 SH | 42,899 dollars | Unchanged Prior quarter: 33,255 | Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row |
| Cerity Partners LLC | 12,812 SH | 16,527 dollars | Unchanged Prior quarter: 12,812 | Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC | 12,090 SH | 15,596 dollars | Unchanged Prior quarter: 12,090 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| HRT FINANCIAL LP | 11,520 SH | 14 dollars | Not in the prior quarter’s filings read | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| Steward Partners Investment Advisory, LLC | 6,000 SH | 7,740 dollars | Unchanged Prior quarter: 6,000 | Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 1,480 SH | 2,013 dollars | Not in the prior quarter’s filings read | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| Allworth Financial LP | 1,000 SH | 1,290 dollars | Not in the prior quarter’s filings read | Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row |
| EFG International AG Partly reported under another manager | 923 SH | 1,191 dollars | Unchanged Prior quarter: 923 | Open filing 0002109868-26-000012 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 346 SH | 446 dollars | Lower by 54,663 Prior quarter: 55,009 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Continuum Advisory, LLC | 50 SH | 65 dollars | Unchanged Prior quarter: 50 | Open filing 0001420506-26-002682 Filed 2026-11-13 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 23 SH | 30 dollars | Not in the prior quarter’s filings read | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| Caitong International Asset Management Co., Ltd | 1 SH | 1 dollars | Lower by 2 Prior quarter: 3 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Maven Securities LTD 809,317 SH
- RENAISSANCE TECHNOLOGIES LLC 11,200 SH
- JANE STREET GROUP, LLC 10,302 SH
- OSAIC HOLDINGS, INC. 152 SH
- MORGAN STANLEY 10 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Sirenia Capital Management LP Ordinary Shares, without par value | 7.7 | 4,054,054.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0000919574-26-003208 Dispute this row |
| Alex Silverstein Ordinary Shares, without par value | 7.7 | 4,054,054.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0000919574-26-003208 Dispute this row |
| Woodline Partners LP Ordinary Shares, no par value | 7.0 | 3,652,190.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0000919574-26-003227 Dispute this row |
| Point72 Asset Management, L.P. Ordinary Shares, no par value | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003508 Dispute this row |
| Point72 Capital Advisors, Inc. Ordinary Shares, no par value | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003508 Dispute this row |
| Steven A. Cohen Ordinary Shares, no par value | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003508 Dispute this row |
| Point72 Asset Management, L.P. Ordinary Shares, no par value | 7.9 | 4,058,445.00 | 02/17/2026 Filed 2026-02-18 | SCHEDULE 13G | Open filing 0000902664-26-001188 Dispute this row |
| Point72 Capital Advisors, Inc. Ordinary Shares, no par value | 7.9 | 4,058,445.00 | 02/17/2026 Filed 2026-02-18 | SCHEDULE 13G | Open filing 0000902664-26-001188 Dispute this row |
| Steven A. Cohen Ordinary Shares, no par value | 7.9 | 4,058,445.00 | 02/17/2026 Filed 2026-02-18 | SCHEDULE 13G | Open filing 0000902664-26-001188 Dispute this row |
| Chernett Jorey Common | 9.5 | 3,802,194.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0002042077-26-000017 Dispute this row |
| Dauntless Investment Group, LLC Common | 1.2 | 471,523.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0002044285-26-000005 Dispute this row |
| Chernett Jorey Common | 7.8 | 2,984,862.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0002042077-25-000008 Dispute this row |
| Dauntless Investment Group, LLC Common | 6.3 | 2,422,048.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0002044285-25-000014 Dispute this row |
| LAURA NATALIA MONICA FONDA Common | 5.01 | 1,928,451.00 | 07/22/2025 Filed 2025-10-29 | SCHEDULE 13G | Open filing 0001493152-25-019998 Dispute this row |
| Dauntless Investment Group, LLC Common | 7.3 | 2,735,780.00 | 06/30/2025 Filed 2025-08-05 | SCHEDULE 13G/AAmendment 1 | Open filing 0001137439-25-000996 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,550,114 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 176,407 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.